COVID-19 Stroke Apical Lung Examination Study
COVID-19 Stroke Apical Lung Examination Study - A Multi-centre Prospective Study
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Nathan Chan, FRCR
- Phone Number: +44(0)7508192126
- Email: covidsalesresearch@gmail.com
Study Contact Backup
- Name: Tom Booth, FRCR
- Phone Number: +44(0)2032993279
- Email: thomas.booth@kcl.ac.uk
Study Locations
-
-
-
Bath, United Kingdom
- Recruiting
- Royal United Hospitals Bath NHS Foundation Trust
-
Principal Investigator:
- Tim Burkett
-
Bristol, United Kingdom
- Recruiting
- North Bristol NHS Trust
-
Contact:
- Teo
-
Principal Investigator:
- Teo Lopez-Bernal
-
Bristol, United Kingdom
- Recruiting
- University Hospitals Bristol NHS Foundation Trust
-
Principal Investigator:
- Teo Lopez-Bernal
-
Camberley, United Kingdom
- Recruiting
- Frimley Health NHS Foundation Trust
-
Principal Investigator:
- Robert Barker
-
Cardiff, United Kingdom
- Recruiting
- Cardiff and Vale University Health Board
-
Principal Investigator:
- Saptarshi Mukherjee
-
Coventry, United Kingdom
- Recruiting
- University Hospitals Coventry and Warwickshire NHS Trust
-
Principal Investigator:
- Ajit Kishore
-
Leeds, United Kingdom
- Recruiting
- Leeds Teaching Hospitals NHS Trust
-
Principal Investigator:
- Jim Zhong
-
London, United Kingdom
- Recruiting
- Guy's and St Thomas' NHS Foundation Trust
-
Principal Investigator:
- Virjen Patel
-
London, United Kingdom
- Recruiting
- Imperial College Healthcare NHS Foundation Trust
-
Principal Investigator:
- Jack Garnham
-
London, United Kingdom
- Recruiting
- King's College Hospital NHS FT (KCH)
-
Contact:
- Thomas Booth
- Phone Number: 02078489568
- Email: thomas.booth@kcl.ac.uk
-
London, United Kingdom
- Recruiting
- King's College Hospital NHS FT (PRUH)
-
Principal Investigator:
- Priyan Tantrige
-
London, United Kingdom
- Recruiting
- University College London NHS Foundation Trust
-
Principal Investigator:
- Indran Davagnanam
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
All adult patients presenting with clinical features of acute ischaemic stroke undergoing investigation with computed tomography angiography at presentation.
Exclusion Criteria:
Poor image quality. No radiologist report available. Computed tomography angiography performed in a non-acute setting.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Accuracy of the computed tomography angiography biomarker relative to the COVID-19 RT-PCR test
Time Frame: 1 month
|
Defined by sensitivity, specificity, positive and negative predictive values
|
1 month
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Prognostic value of the computed tomography biomarker
Time Frame: 1 month
|
Defined by its relationship with 30 day mortality and modified rankin scale following treatment
|
1 month
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Cardiovascular Diseases
- Vascular Diseases
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Coronavirus Infections
- Coronaviridae Infections
- Nidovirales Infections
- RNA Virus Infections
- Virus Diseases
- Infections
- Respiratory Tract Infections
- Respiratory Tract Diseases
- Pneumonia, Viral
- Pneumonia
- Lung Diseases
- Stroke
- COVID-19
- Ischemic Stroke
- Hemorrhagic Stroke
Other Study ID Numbers
Other Study ID Numbers
- COVID SALES 2
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.